Excel Industries Limited Annual Report FY2026

Official PDF · AI Summary · Financial Analysis
Official Annual + Quarterly Filings · AI Business Intelligence
NSE: EXCELINDUS
Sector: Chemicals
Industry: Specialty Chemicals
Source: NSE / BSE
Last Updated: 21 Aug 2026
Business Intelligence Report Verdict
Average
Outlook: Neutral

Quality Scores

Latest Quarterly Earnings Summary

Loading latest quarter…

AI Summary

Excel Industries Limited is a specialized chemical player with a dominant global market position in DETC and Phosphonates. Over the last 10 years, the business has evolved from a mid-sized chemical firm into a key player in pharma intermediates and environmental products, though financial performance remains highly cyclical. While the company maintains an exceptionally strong, nearly debt-free balance sheet, recent years have seen significant pressure on margins and return ratios. The business quality is underpinned by a massive investment portfolio (₹1,126 Cr in FY26) which provides a…

Key Changes in FY2026

The business has transitioned from a traditional chemical manufacturer to a global leader in DETC and a Top 5 global producer of Phosphonates. Over the last decade, the revenue base has expanded from ₹482 Cr in FY15 to ₹1,095 Cr in FY26, representing a steady evolution up the value chain into specialty chemical intermediates and pharma. The balance sheet has undergone a massive transformation, shifting from a debt-reliant structure (₹95 Cr borrowings in FY15) to an almost debt-free status (₹8 Cr in FY26) with a massive investment portfolio. Despite this, the business has faced cyclicality, as seen in the volatile profit trajectory between FY22 and FY24, indicating that the evolution into high-margin specialties is still a work in progress.

Management Commentary

Management exhibits a long-term, stable approach to business, focusing on niche chemical segments where they hold global leadership. Transparency is high, as evidenced by regular investor presentations and clear segment reporting across chemicals and environmental products. The execution in the Phosphonates market has been commendable, maintaining a top-5 global position. However, management has struggled to protect margins during the recent global chemical downturn, leading to a significant drop in profitability. The conservative financial posture suggests a risk-averse leadership style that prioritizes business longevity over aggressive growth. Recent promoter selling (-0.83% in the latest quarter) is a monitorable event, though overall promoter skin in the game remains high at 51.86%.

Financial Highlights

The financial trajectory demonstrates high volatility, with revenue peaking at ₹1,178 Cr in FY22 before contracting and then stabilizing around ₹1,095 Cr in FY26. Operating margins have seen a severe compression from a high of 30% in FY19 to approximately 10% in the latest TTM period. Net profit has followed a similar downward trend, falling from ₹161 Cr in FY22 to ₹76 Cr in FY26, highlighting a lack of pricing power or increased raw material pressures. Return on Equity (ROE) has plummeted from a peak of 21.9% in FY19 to a meager 4.4% in FY26, indicating that recent capital increments are not yielding historical levels of profitability. Despite this, the company maintains a robust net worth of ₹1,703 Cr, largely supported by its investment book rather than core operating accruals.

Major Opportunities

  • Virtually debt-free balance sheet with only 8 Cr debt
  • Market leadership in DETC globally
  • Top 5 global producer of Phosphonates

Major Risks

  • Significant erosion in ROE from 21.9% (FY19) to 4.4% (FY26)
  • Highly volatile Operating Profit Margins
  • Poor sales growth of 7.8% over the last 5 years

About This Annual Report

The Excel Industries Limited FY2026 Annual Report is the company's flagship annual disclosure, filed with NSE / BSE. It covers the full-year business review, management discussion & analysis (MD&A), audited financial statements, director's report, corporate governance report, auditor's report, risk factors, capital allocation, subsidiaries, related-party transactions and ESG initiatives. This page consolidates the official PDF and an AI-generated summary so investors can quickly grasp what changed vs. prior years — sales growth, margin trend, cash flow quality, capex, dividends and management outlook — without having to read the entire filing.

Why Use AI?

  • Summarises hundreds of pages into a focused executive briefing
  • Identifies year-on-year key changes automatically
  • Extracts management commentary and tone
  • Highlights top risks and opportunities
  • Compares business evolution vs. earlier years
  • Answers your questions in plain English via Ask AI

Frequently Asked Questions

Related Research

AI Top Insights — Premium

Unlock deeper AI Top Insights, advanced comparisons, downloadable reports and premium features.